Article
|
Open Access
Featured
-
-
Article
| Open Access
Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver
Structural changes mediated by advanced glycation end-products enhance extracellular matrix viscoelasticity, and that viscoelasticity can promote cancer progression in vivo, independent of stiffness.
- Weiguo Fan
- , Kolade Adebowale
- & Natalie J. Török
-
Article |
Clonal haematopoiesis and risk of chronic liver disease
A study shows that clonal haematopoiesis of indeterminate potential is associated with an increased risk of chronic liver disease specifically through the promotion of liver inflammation and injury.
- Waihay J. Wong
- , Connor Emdin
- & Pradeep Natarajan
-
Article |
Gut bacteria alleviate smoking-related NASH by degrading gut nicotine
Nicotine accumulates in the intestine during tobacco smoking and accelerates the progression of non-alcoholic fatty liver disease to non-alcoholic steatohepatitis (NASH), but it can be degraded effectively by the human symbiont Bacteroides xylanisolvens.
- Bo Chen
- , Lulu Sun
- & Changtao Jiang
-
Article |
Convergent somatic mutations in metabolism genes in chronic liver disease
Whole-genome sequencing analysis of somatic mutations in liver samples from patients with chronic liver disease identifies driver mutations in metabolism-related genes such as FOXO1, and shows that these variants frequently exhibit convergent evolution.
- Stanley W. K. Ng
- , Foad J. Rouhani
- & Peter J. Campbell
-
Article |
Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease
In patients with alcoholic hepatitis, cytolysin-positive Enterococcus faecalis strains are correlated with liver disease severity and increased mortality, and in mouse models these strains can be specifically targeted by bacteriophages.
- Yi Duan
- , Cristina Llorente
- & Bernd Schnabl
-
Article |
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
Single-cell RNA sequencing is used to characterize and compare the functional diversity of cells from liver biopsies of human scarred and normal liver, and identifies markers for scar-associated macrophages and endothelial cells.
- P. Ramachandran
- , R. Dobie
- & N. C. Henderson
-
Outline |
Fighting the fatty liver
Increased levels of obesity are driving an epidemic of non-alcoholic fatty liver disease. Understanding, diagnosing and treating this progressive condition are now priorities.
- Liam Drew
-
Outline |
Fatty liver disease: turning the tide
A progressive and potentially life-threatening condition previously associated with alcoholism is becoming more common — even in non-drinkers.
- Liam Drew
-
Letter |
NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis
Non-alcoholic fatty liver disease (NAFLD) is shown to promote hepatocellular carcinoma through the generation of linoleic acid, disruption of mitochondrial function and selective loss of CD4+ T cells, leading to impaired anti-tumour immunity.
- Chi Ma
- , Aparna H. Kesarwala
- & Tim F. Greten
-
Article |
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
An expansion of Porphyromonadaceae in the gut is linked to the pathogenesis and progression of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis in the mouse.
- Jorge Henao-Mejia
- , Eran Elinav
- & Richard A. Flavell
-
Research Highlights |
Liver disease target
-
News |
Liver-disease mutation corrected in human stem cells
Patient-derived stem cells reprogrammed to become healthier.
- Susan Young
-
Letter |
Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors
- Sayaka Sekiya
- & Atsushi Suzuki
-
News & Views |
An unsuspected drug target
Infection with hepatitis C is one of the main causes of liver disease, yet there are no broadly effective treatments. Discovery of a potent inhibitor of this virus shows that researchers must think outside the box.
- Catherine L. Murray
- & Charles M. Rice
Multimodal decoding of human liver regeneration